Japan Dementia Drug Market Put At ¥242bn In 2022
This article was originally published in PharmAsia News
Executive Summary
The dementia drug market in Japan will be worth ¥242 billion ($2.36 billion) in 2022, ¥100 billion more than in 2013, according to a recent estimate by Fuji Keizai.